CMS issues new reimbursement code for PSMA PET agent Posulma

Sept. 26, 2023

The Centers for Medicare and Medicaid Services issued a pass-through payment reimbursement code for the drug flotufolastat F 18, marketed as Posluma. Tthe code may make it easier for doctors to prescribe the drug for prostate cancer imaging for Medicare patients.